Prof. Kent Roach writes "Ending peremptory challenges in jury selection is a good first step" in Ottawa Citizen

Monday, April 2, 2018

In a commentary in the Ottawa Citizen, Prof. Kent Roach argues that the federal government's proposal in Bill C-75 to eliminate peremptory challenges in jury selection is an important first step towards ensuring representative juries ("Ending peremptory challenges in jury selection is a good first step," April 2, 2018).

Read the full commentary on the Ottawa Citizen website, or below.

The many perspectives on the #MeToo movement: panel discussion on International Women's Day

Wednesday, March 14, 2018

Deepa Mattoo, legal director at the Barbra Schlifer Clinic, lawyer Alexi Wood, filmmaker Sarah PolleyDeepa Mattoo, legal director at the Barbra Schlifer Clinic, lawyer Alexi Wood, filmmaker Sarah Polley

By Lucianna Ciccocioppo / Photos by Wasila Baset and Lucianna Ciccocioppo

 

Profs. Anita Anand and Adriana Robertson write "Has the time come for greater oversight of market indexes?" in Globe and Mail

Monday, March 12, 2018

In a commentary in the Globe and Mail, Profs. Anita Anand and Adriana Robertson point out how influential market indexes are lacking in transparency ("Has the time come for greater oversight of market indexes?", March 10, 2018).

Read the full commentary on the Globe and Mail website, or below.

Prof. Lisa Austin recognized with inaugural U of T President's Impact Award

Wednesday, February 28, 2018
headshot of professor lisa austin

By Lucianna Ciccocioppo / Photo by Jeff Kirk

The Faculty of Law’s Professor Lisa Austin, LLM 1998, is among the first group of scholars to be recognized with the newly announced and prominent University of Toronto President’s Impact Award. She's one of seven recipients for 2018.

The future of legal education: Deans' Roundtable includes University of Toronto, Tsinghua University and the University of Hong Kong

Wednesday, February 14, 2018

The future of legal education is looking international: (left) HKU Law Dean Michael Hor, with U of T Associate Dean Kerry Rittich, moderator, Dean Ed Iacobucci, and Tsinghua Law School's Dean Shen Weixing.

 

By Peter Boisseau

Prof. Kent Roach on how the Canadian legal system fails Indigenous people like Colten Boushie

Wednesday, February 14, 2018

Photo of Colten Boushie
Colten Boushie in a photo posted Nov. 6, 2011 (photo via Facebook)

By Geoffrey Vendeville

The verdict in the Colten Boushie case has provoked outrage across the country and prompted reflection about how the justice system treats Indigenous people. 

Prof. Markus Dubber organizes event series where urban experts tackle Toronto’s most pressing ethical issues

Monday, February 12, 2018

Downtown Toronto
U of T's Centre For Ethics brings experts together to talk about the ethical issues that arise when a city grows and innovates (photo by Photo by Al x via Unsplash)

By Romi Levine

When it comes to ethics, “everyone is an expert and no one is an expert,” says Markus Dubber, a professor in the Faculty of Law and director of the Centre for Ethics at the University of Toronto.

Prof. Jutta Brunnée honoured by American Society of International Law for new book on International Climate Change Law

Thursday, February 1, 2018

International Climate Change LawProfessor Jutta Brunnée, Metcalf Chair in Environmental Law, has won a prestigious 2018 American Society of International Law Certificate of Merit for her new book International Climate Change Law (Oxford University Press, 2017) co-authored with Professors Daniel Bodansky (Arizona State University) and Lavanya Rajamani (Centre for Policy Research, New Delhi).  The ASIL book awards committee pra

Prof. Lemmens is co-principal investigator on CIHR grant to overcome barriers to transparency about drug safety and effectiveness

Wednesday, January 31, 2018

The transparency of research data is increasingly recognized as crucial to reliable, evidence-informed decision-making about health care. Recently, Canada’s Bill C-17 (“Vanessa’s Law”) gave Health Canada the ability to make information about drug safety and effectiveness more transparent. Yet, changing the real world practices of regulators and clinical researchers--much less the pharmaceutical industry--remains a huge challenge.